- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.11. | QLife Holding AB: Update on the reverse takeover process - "Red Chip" structure will not be approved by Nasdaq - other structures are pursued | 192 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or "the Company") and Hipro Biotechnology Co., Ltd. ("Hipro") are working on the planned reverse takeover, as announced in press releases on 5 June 2025 and 5 October 2025.... ► Artikel lesen | |
| 12.11. | Qlife Holding AB Q3 Sales Decline | 1 | RTTNews | ||
| 12.11. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q3, July - September 2025 | 91 | GlobeNewswire (Europe) | Advancing Integration & Innovation: Building a Diagnostics Powerhouse
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary... ► Artikel lesen | |
| 05.10. | QLife Holding AB: The Letter of Intent with Hipro Biotechnology Co., Ltd. regarding reverse takeover has been extended | 69 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") announces an extension of the Letter of Intent regarding a potential reverse takeover (the "Transaction") with Hipro Biotechnology Co., Ltd. ("Hipro"). The... ► Artikel lesen | |
| QLIFE Aktie jetzt für 0€ handeln | |||||
| 22.09. | Qlife Holding AB announces the outcome of the exercise of warrants series TO 6 | 1 | Cision News | ||
| 15.09. | QLife Holding AB: Qlife announces additional product line and progresses two new tests into clinical trials | 119 | GlobeNewswire (Europe) | Qlife, a first mover in clinical-grade home diagnostics, and its partner Hipro Biotechnology are advancing two additional biomarker tests-nt-proBNP and potassium-into clinical trials targeting Congestive... ► Artikel lesen | |
| 27.08. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q2, April to June 2025 | 173 | GlobeNewswire (Europe) | Towards a merger with a vision
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - second quarter 2025
Revenue... ► Artikel lesen | |
| 27.08. | QLife Holding AB: Progress update on the reverse takeover process between Qlife and Hipro | 137 | GlobeNewswire (Europe) | Gothenburg, Sweden - Qlife Holding AB ("Qlife" or the "Company") and Hipro Biotechnology Co., Ltd. ("Hipro") remain fully committed to completing the transaction announced in the Letter of Intent signed... ► Artikel lesen | |
| 21.08. | Qlife Holding AB increases existing credit facility and extends the maturity date | 1 | Cision News | ||
| 21.08. | QLIFE HOLDING AB: Qlife together with Birmingham Women's and Children's NHS Foundation Trust achieve positive results for its rare disease self-test PHE product | 2 | Cision News | ||
| 09.07. | QLIFE HOLDING AB: Qlife resolves to carry out a directed set-off issue of approximately SEK 2.47 million in accordance with previously announced credit facility agreement | 1 | Cision News | ||
| 05.06. | Qlife Holding AB receives observation status | 236 | GlobeNewswire | Today, June 5, 2025, Qlife Holding AB (the "Company") issued a press release with information that it has entered into a letter of intent for a reverse takeover of Hipro Biotechnology Co., Ltd.,... ► Artikel lesen | |
| 05.06. | QLife Holding AB: Qlife enters letter of intent with Hipro Biotechnology Co., Ltd. to join forces through a reverse takeover | 225 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") has entered into a non-binding letter of intent ("Letter of Intent") with Hipro Biotechnology Co., Ltd., registration no. 91130100794182204D, ("Hipro") regarding... ► Artikel lesen | |
| 28.05. | QLife Holding AB: Bulletin from the annual general meeting 2025 of Qlife Holding AB | 151 | GlobeNewswire (Europe) | Qlife Holding AB held its annual general meeting on 28 May 2025. At the meeting, the following resolutions were made.
The English text is an unofficial translation. In case of any discrepancies between... ► Artikel lesen | |
| 20.05. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q1, January to March 2025 | 302 | GlobeNewswire (Europe) | Progress on all levels
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - first quarter 2025
Revenue in the... ► Artikel lesen | |
| 25.03. | QLife Holding AB: Qlife announces that it has received approval from UK authorities to initiate a clinical trial in the UK | 223 | GlobeNewswire (Europe) | The Egoo Phe System, developed to measure phenylalanine (Phe) levels associated with the PKU condition, is now entering its final phase ahead of initial registration in the UK and submission to a Notified... ► Artikel lesen | |
| 21.03. | QLife Holding AB: Bulletin from the extraordinary general meeting in Qlife Holding AB on 21 March 2025 | 262 | GlobeNewswire (Europe) | Today, on 21 March 2025, an extraordinary general meeting was held in Qlife Holding AB. A summary of the adopted resolutions follows below.
Election and remuneration of the board of directors
The... ► Artikel lesen | |
| 04.03. | The observation status for Qlife Holding AB is removed | 218 | GlobeNewswire | On February 13, 2024, Qlife Holding AB (the "Company") was given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On February 26... ► Artikel lesen | |
| 26.02. | QLife Holding AB: Qlife announces outcome in rights issue | 319 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 17.02. | QLife Holding AB: Qlife announces the launch of Egoo.AI and the start of sales for the Women's Health platform | 385 | GlobeNewswire (Europe) | Qlife is proud to announce a major expansion of Egoo.Health with the launch of Egoo.AI, an advanced AI-driven platform designed to provide users with personalized insights based on biomarker test results... ► Artikel lesen |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MOUNTAIN VALLEY MD | 0,004 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| GENEDX | 167,52 | 0,00 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| PROGYNY | 26,770 | 0,00 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action | ||
| ALIGNMENT HEALTHCARE | 19,150 | 0,00 % | Alignment Healthcare stock rating upgraded by JPMorgan to Overweight | ||
| CASTLE BIOSCIENCES | 39,930 | 0,00 % | Castle Biosciences: Starke Wachstumsdynamik und erhöhte Umsatzprognose | ||
| PRIVIA HEALTH GROUP | 24,560 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,270 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 36,210 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ADAPTHEALTH | 9,680 | -1,83 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| SIEMENS HEALTHINEERS | 42,440 | -0,21 % | BARCLAYS stuft Siemens Healthineers auf 'Positiv' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Siemens Healthineers von 61,00 auf 61,50 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktienkurse... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,630 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,310 | -0,86 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 51 auf 48 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Die Aktienkurse der europäischen... ► Artikel lesen | |
| PACS GROUP | 31,820 | 0,00 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BILLIONTOONE | 129,90 | 0,00 % | BillionToOne, Inc.: BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced... ► Artikel lesen | |
| NUTEX HEALTH | 119,20 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports September 30, 2025 Third Quarter And Year-to-date Financial Results | Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5%
Net... ► Artikel lesen |
QLIFE HOLDING AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,003 (-2,90 %) liegt der Kurs bei 0,101 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QLIFE HOLDING AB finden Sie auf Wallstreet Online.